About: COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 among fit patients with CLL treated with venetoclax-based combinations Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Creator	Gregor, • Wendtner, Clemens Van Der Spek, Ellen Arnon, • Carsten, • De Silva, Nisha Droogendijk, Jolanda Eichhorst, Barbara Fink, Anna Fischer, Kirsten Fürstenau, Moritz Hohloch, Karin Kater, P Langerbeins, Petra Niemann, U Robrecht, Sandra Schöttker, Björn Simon, Florian Stilgenbauer, Stephan Tausch, Eugen Hallek, • Marjolein Van Der Klift, • Thomas Illmer, • Von Tresckow, Julia
Source	Medline; PMC
abstract	covid:b39517343be00324847e69c99001d5a1d25452c6#abstract
has issue date	2020-06-29(xsd:dateTime)
bibo:doi	10.1038/s41375-020-0941-7
bibo:pmid	32601378
has license	cc-by
sha1sum (hex)	b39517343be00324847e69c99001d5a1d25452c6
schema:url	https://doi.org/10.1038/s41375-020-0941-7
resource representing a document's title	COVID-19 among fit patients with CLL treated with venetoclax-based combinations
has PubMed Central identifier	PMC7323604
has PubMed identifier	32601378
schema:publication	Leukemia
resource representing a document's body	covid:b39517343be00324847e69c99001d5a1d25452c6#body_text
is schema:about of	named entity 'fit' named entity 'venetoclax' named entity 'single-agent' named entity 'rituximab' named entity 'T-cell' named entity 'venetoclax' named entity 'comorbidities' named entity 'asymptomatic' named entity 'intensive care unit' named entity 'rituximab' named entity 'CLL' named entity 'venetoclax' named entity 'COVID' named entity 'COVID-19' named entity 'malignant' named entity 'CLL' named entity 'fludarabine' named entity 'TP53' named entity 'ICU' named entity 'risk factors' named entity 'infection' named entity 'chemoimmunotherapy' named entity 'CIRS' named entity 'COVID' named entity 'DSMB' named entity 'ICU' named entity 'rituximab' named entity 'first-line treatment' named entity 'supportive care' named entity 'venetoclax' named entity 'immune deficiency' named entity 'immune defects' named entity 'immune function' named entity 'venetoclax' named entity 'mechanical ventilation' named entity 'tyrosine kinase' named entity 'cyclophosphamide' named entity 'clinical trial' named entity 'invasive mechanical ventilation' named entity 'COVID' named entity 'BTK inhibitor' named entity 'case series' named entity 'CLL' named entity 'leukemia' named entity 'SARS-CoV-2' named entity 'CD4+' named entity 'Hospital Clinic of Barcelona' named entity 'venetoclax' named entity 'Chronic lymphocytic leukemia' named entity 'severe infections' named entity 'immune suppression' named entity 'respiratory disease' named entity 'successful treatment' named entity 'COVID' named entity 'venetoclax' named entity 'meta-analyses' named entity 'study population' named entity 'CD3+'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software